- Home
- FULC
FULC
Fulcrum Therapeutics Inc.
as 05-09-2025 4:00pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $6.57 | AVG Volume (30 days): | 679.9K |
| Analyst Decision: | Hold | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.31 - $10.13 | Next Earning Date: | 05-01-2025 |
| Revenue: | $80,000,000 | Revenue Growth: | 3087.25% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Fulcrum Therapeutics Inc. News
FULC Breaking Stock News: Dive into FULC Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Fulcrum Therapeutics to Participate in Upcoming May Conferences
GuruFocus.com
8 days ago
Fulcrum Therapeutics Inc (FULC) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions and ...
Thomson Reuters StreetEvents
8 days ago
Q1 2025 Fulcrum Therapeutics Inc Earnings Call
GlobeNewswire
9 days ago
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
GlobeNewswire
16 days ago
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
GlobeNewswire
a month ago
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
a month ago
We're Interested To See How Fulcrum Therapeutics (NASDAQ:FULC) Uses Its Cash Hoard To Grow
GlobeNewswire
2 months ago
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
Compare FULC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FULC Fulcrum Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.